Former finance guru and TV personality Sam Henderson has been banned from providing financial services for three years after an ASIC surveillance operation and shock revelations from the banking royal commission that one of his staff members impersonated a Fair Work commissioner.
Construction giant Lendlease faces a second shareholder class action over market disclosures relating to its underperforming engineering division, and joining the case is one of the biggest public pension funds in the US.
A judge has slapped a $10 million fine on online supplement company Peptide Clinics for advertising prescription-only drugs in breach of the Therapeutic Goods Act.
Insolvency firm Kordamentha has filed proceedings against ten former directors of the Arrium Group, accusing them of breaching of their duties to prevent insolvent trading after the steel giant collapsed with almost $4 billion in debt.
A judge overseeing a lease dispute in relation to a Brisbane CBD office tower has slashed a $43.2 million statutory demand against construction company Grocon by more than two thirds, finding property management firm Dexus was unreasonable to demand payment just two business days after issuing its invoices.
Pitcher Partners has lost it challenge to a ruling socking it with a $5.6 million bill for an accounting error concealed from client Neville’s Bus Service, with an appeals court saying there was a “clear and principled basis” to require the accounting firm to pay the sum awarded for loss and damage to the transport company.
Certain executives of Australian companies might have to wait seven years to have their bonuses paid out under proposed changes to executive remuneration introduced by the Australian Prudential Regulation Authority designed to limit the risk of misconduct and align executive pay with long-term performance.
The settlement of the Discovery Metals investor class action against KPMG has experienced another setback, after scheme administrator Grant Thornton flagged a potential conflict of interest in acting as a costs contradictor over Piper Aldermanās controversial $3.5 million legal bill.
Mylan has launched a lawsuit against Cipla for allegedly copying the get-up of its blockbuster cholesterol drug Lipidil, after losing a bid to block Cipla and Sun Pharma from selling generic versions of the drug while it appeals a ruling invalidating several claims of its patents.
Patents at the centre of a high stakes IP dispute between tech giants Motorola and Hytera have significantly more than the necessary āscintilla of inventivenessā to be deemed valid, Motorola said on the first day of a month-long trial.